Antibody-mediated immune suppression by antigen modulation is antigen-specific

Area of Science:

• Immunology
• Transfusion Medicine
• Red Blood Cell Alloimmunization

Background:

• Alloantibodies against red blood cell (RBC) antigens pose risks in pregnancy and transfusions.
• Antibody-mediated immune suppression (AMIS) is the only active method to inhibit RBC alloantibody formation.
• The specificity of AMIS for multiple antigens on a single RBC is not well understood.

Purpose of the Study:

• To investigate whether antibody-mediated immune suppression (AMIS) is antigen-specific.
• To determine if passive antibody administration inhibits alloimmunization to specific RBC antigens.

Main Methods:

• Passive immunization of recipients with anti-KEL or anti-hen egg lysozyme (HEL) antibodies.
• Transfusion of RBCs expressing both HEL-ovalbumin-Duffy (HOD) and KEL antigens.
• Analysis of immunoglobulin G and complement deposition, antigen modulation, and antibody formation.

Main Results:

• Passive antibodies led to antigen-specific modulation of RBC antigens (KEL or HEL).
• Antigen loss mechanisms differed: KEL removal involved complement and was clodronate-sensitive; HEL removal was protease-sensitive.
• Recipients developed antibodies to the non-targeted antigen, indicating antigen-specific immune suppression.

Conclusions:

• Passively administered antibodies selectively inhibit immune responses to specific RBC antigens.
• AMIS is a targeted approach that can prevent alloimmunization to particular antigens without affecting others.
• Findings support the potential for antigen-specific strategies in managing transfusion and pregnancy-related alloimmunization.